Skip to content
HeyJared

Scott Gavura

Reporter

Indexed articles, last 90 days
2
Latest publication
Jul 30, 2026
Outlet visibility, for Science-Based Medicine
Top 5M sites
Earliest in this view
Jul 16, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Jul 30, 2026 · Scott Gavura

    The FDA vs. Compounding Pharmacies: GLP-1 Edition (opens the original)

    Excerpt

    Read excerpt

    The FDA is determined to stop the sale of compounded GLP-1 drugs The post The FDA vs. Compounding Pharmacies: GLP-1 Edition first appeared on Science-Based Medicine.

  2. Article · Jul 16, 2026 · Scott Gavura

    Science vs. Hype: The Unproven Promise of NAD+ IV Therapy (opens the original)

    Excerpt · Critical tone

    Read excerpt

    Two new papers and renewed safety concerns for this popular (yet unproven) therapy. The post Science vs. Hype: The Unproven Promise of NAD+ IV Therapy first appeared on Science-Based Medicine.

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 5M sites

For Science-Based Medicine, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Scott Gavura